Covalon Receives Canadian Patent for Drug Delivery Via Therapeutic Hydrogels
Posted on: Monday, 31 March 2008, 03:00 CDT
Covalon Technologies, an advanced medical biosystems company, has received a notice of allowance for a Canadian patent for drug delivery via therapeutic hydrogels.
The company said that the technology can be used for site-specific delivery of several drugs in a time-release fashion from combination medical devices. The patent reportedly augments and strengthens Covalon's technology position in the expanding area of combination medical devices.
According to Covalon, the devices that may benefit from the technology include implantable medical devices, wound closure systems and wound dressings that can contain a variety of active agents such as antibiotics, hormones, growth factors and other therapeutics that are beneficial for the medical condition under management.
Source: Datamonitor
Related Articles
- Medical Devices Help Boost J&J Profit
- Report: Monitoring Needed of Medical Devices for Children
- Medical Devices for Children Need More Oversight: Report
- Medical device monitoring needs work - report
- Business Opportunities in the Arabian Gulf Medical Device and Equipment Markets Accelerated By Growth in Population
- Overland, Mo.-Based Medical Device Firm May Sell Ultrasound Machine
- Doctors Need More Medical Devices for Babies
- More Medical Devices Needed for Babies
- FDA Approves Leeches As Medical Devices in U.S.
- Medical Devices Maker Pleads Guilty
 |
 |
User Comments (0)
RSS Feeds